1. Home
  2. RAIL vs UNCY Comparison

RAIL vs UNCY Comparison

Compare RAIL & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FreightCar America Inc.

RAIL

FreightCar America Inc.

HOLD

Current Price

$7.98

Market Cap

149.9M

Sector

Industrials

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$5.30

Market Cap

145.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAIL
UNCY
Founded
1901
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Railroads
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.9M
145.3M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
RAIL
UNCY
Price
$7.98
$5.30
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$25.67
AVG Volume (30 Days)
349.0K
2.6M
Earning Date
05-04-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
134.94
N/A
EPS
1.15
N/A
Revenue
$500,991,000.00
$675,000.00
Revenue This Year
$6.54
N/A
Revenue Next Year
$30.90
$582.86
P/E Ratio
$7.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.27
$3.72
52 Week High
$14.90
$8.74

Technical Indicators

Market Signals
Indicator
RAIL
UNCY
Relative Strength Index (RSI) 39.96 38.30
Support Level $7.58 $4.18
Resistance Level $8.12 $5.59
Average True Range (ATR) 0.54 0.73
MACD -0.19 -0.17
Stochastic Oscillator 10.27 29.48

Price Performance

Historical Comparison
RAIL
UNCY

About RAIL FreightCar America Inc.

FreightCar America Inc is a diversified manufacturer and supplier of railcars and railcar components. It designs and manufactures a variety of railcar types for transportation of bulk commodities and containerized freight products in North America. The company also provides railcar rebody and repair services, railcar conversion services, and supplies railcar parts. The company has two segments: Manufacturing and Aftermarket. The majority of the company's revenue is derived from the Manufacturing segment, which includes new railcar manufacturing, used railcar sales, and various conversions and rebodies. Geographically, it generates the maximum revenue from the United States.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: